Ox-LDL-induced LOX-1 expression in vascular smooth muscle cells: Role of reactive oxygen species

Fundamental and Clinical Pharmacology

Volumn 25, Issue 5, 2011, Pages 572-579

  Sun, Yiyi ^a   Chen, Xiuping ^b  

^a CHENGDU MEDICAL COLLEGE   (China)

^b University of Macau   (Macao)

Author keywords

Lectin like oxidized low density lipoprotein receptor 1; Oxidized low density lipoprotein; Reactive oxygen species; Vascular smooth muscle cells

Indexed keywords

ACETYLCYSTEINE; ACETYLSALICYLIC ACID; ALLOPURINOL; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; APOCYNIN; ASCORBIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; JANUS KINASE; MESSENGER RNA; NORDIHYDROGUAIARETIC ACID; OXIDIZED LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; PYRROLIDINE DITHIOCARBAMATE; REACTIVE OXYGEN METABOLITE; ROTENONE; SYNAPTOTAGMIN I; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; DRUG EFFECT; ENZYME PHOSPHORYLATION; FLOW CYTOMETRY; FLUORESCENCE ANALYSIS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

EID: 80052901862     PISSN: 07673981     EISSN: 14728206     Source Type: Journal    
DOI: 10.1111/j.1472-8206.2010.00885.x     Document Type: Article

References (38)

1. Witztum J.L., Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J. Clin. Invest. (1991) 88 1785-1792.
2. Kita T., Kume N., Minami M. et al. Role of oxidized LDL in atherosclerosis. Ann. N Y Acad. Sci. (2001) 947 199-205.
3. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature (1993) 362 801-809.
4. Steinberg D., Lewis A. Conner Memorial Lecture. Oxidative modification of LDL and atherogenesis. Circulation (1997) 95 1062-1071.
5. Adachi H., Tsujimoto M. Endothelial scavenger receptors. Prog. Lipid Res. (2006) 45 379-404.
6. Dhaliwal B.S., Steinbrecher U.P. Scavenger receptors and oxidized low density lipoproteins. Clin. Chim. Acta (1999) 286 191-205.
7. Zmijewski J.W., Moellering D.R., Le Goffe C., Landar A., Ramachandran A., Darley-Usmar V.M. Oxidized LDL induces mitochondrially associated reactive oxygen/nitrogen species formation in endothelial cells. Am. J. Physiol. Heart Circ. Physiol. (2005) 289 H852-H861.
8. Cominacini L., Rigoni A., Pasini A.F. et al. The binding of oxidized low density lipoprotein (ox-LDL) to ox-LDL receptor-1 reduces the intracellular concentration of nitric oxide in endothelial cells through an increased production of superoxide. J. Biol. Chem. (2001) 276 13750-13755.
9. Cominacini L., Pasini A.F., Garbin U. et al. Oxidized low density lipoprotein (ox-LDL) binding to ox-LDL receptor-1 in endothelial cells induces the activation of NF-kappaB through an increased production of intracellular reactive oxygen species. J. Biol. Chem. (2000) 275 12633-12638.
10. Hsieh C.C., Yen M.H., Yen C.H., Lau Y.T. Oxidized low density lipoprotein induces apoptosis via generation of reactive oxygen species in vascular smooth muscle cells. Cardiovasc. Res. (2001) 49 135-145.
11. Simopoulou T., Malizos K.N., Tsezou A. Lectin-like oxidized low density lipoprotein receptor 1 (LOX-1) expression in human articular chondrocytes. Clin. Exp. Rheumatol. (2007) 25 605-612.
12. Sawamura T., Kume N., Aoyama T. et al. An endothelial receptor for oxidized low-density lipoprotein. Nature (1997) 386 73-77.
13. Chen X.P., Zhang T.T., Du G.H. Lectin-like oxidized low-density lipoprotein receptor-1, a new promising target for the therapy of atherosclerosis? Cardiovasc. Drug. Rev. (2007) 25 146-161.
14. Chen M., Masaki T., Sawamura T. LOX-1, the receptor for oxidized low-density lipoprotein identified from endothelial cells: implications in endothelial dysfunction and atherosclerosis. Pharmacol. Ther. (2002) 95 89-100.
15. Draude G., Hrboticky N., Lorenz R.L. The expression of the lectin-like oxidized low-density lipoprotein receptor (LOX-1) on human vascular smooth muscle cells and monocytes and its down-regulation by lovastatin. Biochem. Pharmacol. (1999) 57 383-386.
16. Yoshida H., Kondratenko N., Green S., Steinberg D., Quehenberger O. Identification of the lectin-like receptor for oxidized low-density lipoprotein in human macrophages and its potential role as a scavenger receptor. Biochem. J. (1998) 334(Pt 1) 9-13.
17. Kume N., Moriwaki H., Kataoka H. et al. Inducible expression of LOX-1, a novel receptor for oxidized LDL, in macrophages and vascular smooth muscle cells. Ann. N Y Acad. Sci. (2000) 902 323-327.
18. Mukai E., Kume N., Hayashida K. et al. Heparin -binding EGF-like growth factor induces expression of lectin-like oxidized LDL receptor-1 in vascular smooth muscle cells. Atherosclerosis (2004) 176 289-296.
19. Limor R., Kaplan M., Sawamura T. et al. Angiotensin II increases the expression of lectin-like oxidized low-density lipoprotein receptor-1 in human vascular smooth muscle cells via a lipoxygenase -dependent pathway. Am. J. Hypertens. (2005) 18 299-307.
20. Nishimura S., Akagi M., Yoshida K. et al. Oxidized low-density lipoprotein (ox-LDL) binding to lectin-like ox-LDL receptor-1 (LOX-1) in cultured bovine articular chondrocytes increases production of intracellular reactive oxygen species (ROS) resulting in the activation of NF-kappaB. Osteoarthritis Cartilage (2004) 12 568-576.
21. Hu C., Dandapat A., Mehta J.L. Angiotensin II induces capillary formation from endothelial cells via the LOX-1 dependent redox-sensitive pathway. Hypertension (2007) 50 952-957.
22. Dandapat A., Hu C., Sun L., Mehta J.L. Small concentrations of oxLDL induce capillary tube formation from endothelial cells via LOX-1-dependent redox-sensitive pathway. Arterioscler. Thromb. Vasc. Biol. (2007) 27 2435-2442.
23. Chen X.P., Xun K.L., Wu Q., Zhang T.T., Shi J.S., Du G.H. Oxidized low density lipoprotein receptor-1 mediates oxidized low density lipoprotein-induced apoptosis in human umbilical vein endothelial cells: role of reactive oxygen species. Vascul. Pharmacol. (2007) 47 1-9.
24. Hsieh C.C., Lau Y. Migration of vascular smooth muscle cells is enhanced in cultures derived from spontaneously hypertensive rat. Pflugers Arch. (1998) 435 286-292.
25. Havel R.J., Eder H.A., Bragdon J.H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. (1955) 34 1345-1353.
26. Cominacini L., Garbin U., Davoli A. et al. A simple test for predisposition to LDL oxidation based on the fluorescence development during copper-catalyzed oxidative modification. J. Lipid Res. (1991) 32 349-358.
27. Cominacini L., Garbin U., De Santis A. et al. Mechanisms involved in the in vitro modification of low density lipoprotein by human umbilical vein endothelial cells and copper ions. J. Lipid Mediat. Cell Signal. (1996) 13 19-33.
28. Zhou M.S., Jaimes E.A., Raij L. Inhibition of oxidative stress and improvement of endothelial function by amlodipine in angiotensin II-infused rats. Am. J. Hypertens. (2004) 17 167-171.
29. Eto H., Miyata M., Kume N. et al. Expression of lectin-like oxidized LDL receptor-1 in smooth muscle cells after vascular injury. Biochem. Biophys. Res. Commun. (2006) 341 591-598.
30. Taillé C., El-Benna J., Lanone S., Boczkowski J., Motterlini R. Mitochondrial respiratory chain and NAD(P)H oxidase are targets for the antiproliferative effect of carbon monoxide in human airway smooth muscle. J. Biol. Chem. (2005) 280 25350-25360.
31. Mehta J.L., Chen J., Yu F., Li D.Y. Aspirin inhibits ox-LDL-mediated LOX-1 expression and metalloproteinase-1 in human coronary endothelial cells. Cardiovasc. Res. (2004) 64 243-249.
32. Halvorsen B., Staff A.C., Henriksen T., Sawamura T., Ranheim T. 8-iso- prostaglandin F(2alpha) increases expression of LOX-1 in JAR cells. Hypertension (2001) 37 1184-1190.
33. Nagase M., Ando K., Nagase T., Kaname S., Sawamura T., Fujita T. Redox- sensitive regulation of lox-1 gene expression in vascular endothelium. Biochem. Biophys. Res. Commun. (2001) 281 720-725.
34. Sakurai K., Sawamura T. Stress and vascular responses: endothelial dysfunction via lectin-like oxidized low-density lipoprotein receptor-1: close relationships with oxidative stress. J. Pharmacol. Sci. (2003) 91 182-186.
35. Schreck R., Rieber P., Baeuerle P.A. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J. (1991) 10 2247-2258.
36. Weber C., Erl W., Pietsch A., Strobel M., Ziegler-Heitbrock H.W., Weber P.C. Antioxidants inhibit monocyte adhesion by suppressing nuclear factor-kappa B mobilization and induction of vascular cell adhesion molecule-1 in endothelial cells stimulated to generate radicals. Arterioscler. Thromb. (1994) 14 1665-1673.
37. Nakano H., Nakajima A., Sakon-Komazawa S., Piao J.H., Xue X., Okumura K. Reactive oxygen species mediate crosstalk between NF-kappaB and JNK. Cell Death Differ. (2006) 13 730-737.
38. Bubici C., Papa S., Pham C.G., Zazzeroni F., Franzoso G. The NF-kappaB -mediated control of ROS and JNK signaling. Histol. Histopathol. (2006) 21 69-80.